An unusual giant cell tumor of the thyroid: Case report and review of the literature

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 1, 2013, Pages 1-6

  Derbel, O ^a   Zrounba, P ^a   Chassagne Clement C ^a   Decouvelaere, A V ^a   Orlandini, F ^a   Duplomb, S ^a   Blay, J Y ^a   De La Fouchardiere, C ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; DENOSUMAB; FLUORODEOXYGLUCOSE F 18; KI 67 ANTIGEN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P63; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ADJUVANT THERAPY; ADULT; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DOPPLER ECHOGRAPHY; DYSPHAGIA; FINE NEEDLE ASPIRATION BIOPSY; GIANT CELL TUMOR; GIANT CELL TUMOR OF THE THYROID CARTILAGE; HISTOPATHOLOGY; HOARSENESS; HUMAN; HUMAN TISSUE; LARYNGECTOMY; LOADING DRUG DOSE; MALE; MONONUCLEAR CELL; OSSIFICATION; OSTEOCLAST; POORLY DIFFERENTIATED THYROID CANCER; PRIORITY JOURNAL; SURGICAL RISK; THYROID NODULE; THYROIDECTOMY; TUMOR CALCINOSIS;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; GIANT CELL TUMORS; HUMANS; MALE; NEOPLASM, RESIDUAL; THYROID NEOPLASMS;

EID: 84872066753     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2306     Document Type: Conference Paper

References (39)

1. Bitoh S, Takimoto N, Nakagawa H, Namba J, Sakaki S, Gohma T 1978 Giant cell tumor of the skull. Surg Neurol 9:185-188
2. Qureshi SS, Puri A, Agarwal M, Desai S, Jambhekar N 2005 Recurrent giant cell tumor of bone with simultaneous regional lymph node and pulmonary metastases. Skeletal Radiol 34:225-228
3. Dickson BC, Li SQ, Wunder JS, Ferguson PC, Eslami B, Werier JA, Turcotte RE, Kandel RA 2008 Giant cell tumor of bone express p63. Mod Pathol 21:369-375
4. Baba Y, Nosho K, Shima K, Hayashi M, Meyerhardt JA, Chan AT, Giovannucci E, Fuchs CS, Ogino S 2011 Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers. Cancer 117:1399-1408
5. Goldring SR, Roelke MS, Petrison KK, Bhan AK 1987 Human giant cell tumors of bone identification and characterization of cell types. J Clin Invest 79:483-491
6. Cameron JA, Marsden AT, Lumpur K 1952 Malignant osteoclastoma. J Bone Joint Surg Br 34-B:93-96
7. Murata A, Fujita T, Kawahara N, Tsuchiya H, Tomita K 2005 Osteoblast lineage properties in giant cell tumors of bone. J Orthop Sci 10:581-588
8. Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N 2005 Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol 36:945-954
9. Salerno M, Avnet S, Alberghini M, Giunti A, Baldini N 2008 Histogenetic characterization of giant cell tumor of bone. Clin Orthop Relat Res 466:2081-2091
10. Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G 2008 Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 134:969-978
11. Emley WE 1971 Giant cell tumor of the sphenoid bone. A case report and review of the literature. Arch Otolaryngol 94:369-374
12. Company MM, Ramos R 2009 Giant cell tumor of the sphenoid. Arch Neurol 66:134-135
13. Commins DJ, O'Malley S, Athanasou NA, Jalloh S 1999 Giant cell tumour of the hyoid - first reported case. J Laryngol Otol 113:566-568
14. Khademi B, Gandomi B 2001 Giant cell reparative granuloma of the hyoid bone. Otolaryngol Head Neck Surg 124:117-118
15. Wieneke JA, Gannon FH, Heffner DK, Thompson LD 2001 Giant cell tumor of the larynx: a clinicopathologic series of eight cases and a review of the literature. Mod Pathol 14:1209-1215
16. Wallin G, Lundell G, Tennvall J 2004 Anaplastic giant cell thyroid carcinoma. Scand J Surg 93:272-277
17. Wong KK, Seikaly H 2004 Giant cell tumour of the larynx: case report and review of the literature. J Otolaryngol 33:195-197
18. Osaka S, Sugita H, Osaka E, Yoshida Y, Ryu J, Hemmi A, Suzuki K 2004 Clinical and immunohistochemical characteristics of benign giant cell tumour of bone with pulmonary metastases: case series. J Orthop Surg (Hong Kong) 12:55-62
19. Strauss LG, Dimitrakopoulou-Strauss A, Koczan D, Bernd L, Haberkorn U, Ewerbeck V, Thiesen HJ 2004 18F-FDG kinetics and gene expression in giant cell tumors. J Nucl Med 45:1528-1535
20. McKinney AM, Reichert P, Short J, Dhurairaj T, Santa Cruz K, McKinney Z, Kieffer S 2006 Metachronous, multicentric giant cell tumor of the sphenoid bone with histologic, CT, MR imaging, and positron-emission tomography/CT correlation. AJNR Am J Neuroradiol 27:2199-2201
21. Kostakoglu L, Agress Jr H, Goldsmith SJ 2003 Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23:315-340
22. Vult von Steyern F, Bauer HC, Trovik C, Kivioja A, Bergh P, Holmberg Jörgensen P, Follerås G, Rydholm A 2006 Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study. J Bone Joint Surg Br 88:531-535
23. Biagini R, Boriani S, Bandiera S, Casadei R, Favale L, Salducca N, Erba F, Lari S, Gamberini G, Mercuri M 2003 Substitution in vertebral resections. Chir Organi Mov 88:185-191
24. Siebenrock KA, Unni KK, Rock MG 1998 Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up. J Bone Joint Surg Br 80:43-47
25. Seider MJ, Rich TA, Ayala AG, Murray JA 1986 Giant cell tumors of bone: treatment with radiation therapy. Radiology 161:537-540
26. Leggon RE, Zlotecki R, Reith J, Scarborough MT 2004 Giant cell tumor of the pelvis and sacrum: 17 cases and analysis of the literature. Clin Orthop Relat Res 423:196-207
27. Roeder F, Timke C, Zwicker F, Thieke C, Bischof M, Debus J, Huber PE 2010 Intensity modulated radiotherapy (IMRT) in benign giant cell tumors - a single institution case series and a short review of the literature. Radiat Oncol 5:18
28. Mittal S, Goswami C, Kanoria N, Bhattacharya A 2007 Post-irradiation angiosarcoma of bone. J Cancer Res Ther 3:96-99
29. Balke M, Hardes J 2010 Denosumab: a breakthrough in treatment of giant-cell tumour of bone? Lancet Oncol 11:218-219
30. Chang SS, Suratwala SJ, Jung KM, Doppelt JD, Zhang HZ, Blaine TA, Kim TW, Winchester RJ, Lee FY 2004 Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis. Clin Orthop Relat Res 426:103-109
31. Cheng YY, Huang L, Lee KM, Xu JK, Zheng MH, Kumta SM 2004 Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif Tissue Int 75:71-77
32. Fujimoto N, Nakagawa K, Seichi A, Terahara A, Tago M, Aoki Y, Hosoi Y, Ohtomo K 2001 A new bisphosphonate treatment option for giant cell tumors. Oncol Rep 8:643-647
33. Kyrgidis A, Toulis K 2010 Safety and efficacy of denosumab in giant-cell tumour of bone. Lancet Oncol 11:513-514
34. Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S 2010 Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11:275-280
35. Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF 2008 Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone 42:68-73
36. Body JJ, Facon T, Coleman RE, Lipton A, Geurs F, Fan M, Holloway D, Peterson MC, Bekker PJ 2006 A study of the biological receptor activator of nuclear factor-κB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. Clin Cancer Res 12:1221-1228
37. Fizazi K, Lipton A, Mariette X, Body JJ, Rahim Y, Gralow JR, Gao G, Wu L, Sohn W, Jun S 2009 Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. J Clin Oncol 27:1564-1571
38. Lipton A, Steger GG, Figueroa J, Alvarado C, Solal-Celigny P, Body JJ, de Boer R, Berardi R, Gascon P, Tonkin KS, Coleman R, Paterson AH, Peterson MC, Fan M, Kinsey A, Jun S 2007 Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases. J Clin Oncol 25:4431-4437
39. Blay J, Chawla SP, Martin Broto J, Choy E, Dominkus M, Engellau J, Grimer R, Henshaw RM, Palmerini E, Reichardt P, Rutkowski P, Skubitz KM, Thomas DM, Zhao Y, Qian Y, Jacobs IA, Denosumab safety and efficacy in giant cell tumor of bone (GCTB): interim results from a phase II study. Proc 47th Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 2011 (Abstract 10034)